Indocyangreen Elimination in Cirrhosis and Acute Liver Failure

NCT00245310 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2010-10-11

No results posted yet for this study

Summary

Indocyangreen (ICG)is totally biliary eliminated and corresponds to hepatocyte function and liver perfusion.

The ICG-clearance will be evaluated as a prognostic marker in liver disease.

Conditions

Interventions

PROCEDURE

Indocyangreen (ICG) clearance

Sponsors & Collaborators

  • Heidelberg University

    lead OTHER

Principal Investigators

  • Jens Encke, PD Dr. med. · Heidelberg University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2010-10-31
Completion
2010-10-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00245310 on ClinicalTrials.gov